Axsome Therapeutics, Inc. (AXSM)
NASDAQ · Healthcare
Axsome Therapeutics, Inc. Cash on Hand 2022–2025
Axsome Therapeutics, Inc. annual cash on hand history from 2022 to 2025. Cash on hand refers to the total amount of cash and cash equivalents held by a company.
- Axsome Therapeutics, Inc. cash on hand as of December 31, 2025: 322.9M, a 2.40% increase year-over-year.
- Axsome Therapeutics, Inc. cash on hand for 2025 were 322.9M, a 2.40% increase from 2024.
- Axsome Therapeutics, Inc. cash on hand for 2024 were 315.4M, a 18.34% decrease from 2023.
- Axsome Therapeutics, Inc. cash on hand for 2023 were 386.2M, a 92.29% increase from 2022.
- Axsome Therapeutics, Inc. cash on hand for 2022 were 200.8M.
Cash on Hand
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Axsome Therapeutics, Inc. Annual Cash on Hand (Millions of US $) | |
|---|---|
| 2025 | $323 |
| 2024 | $315 |
| 2023 | $386 |
| 2022 | $201 |
Axsome Therapeutics, Inc. Cash on Hand — FAQ
Axsome Therapeutics, Inc. (AXSM) cash on hand over the last 4 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see AXSM's cash on hand history?
The chart and table above show Axsome Therapeutics, Inc.'s cash on hand by year and by quarter, including the growth rate.